Open AccessCHANGES IN THE MGMT GENE EXPRESSION IN PATIENTS WITH PRIMARY GLIOBLASTOMA AFTER RELAPSE. INFLUENCE OF CLINICAL CHARACTERISTICS AND MGMT EXPRESSION ON SURVIVAL OF PATIENTS
Author(s) -
М. В. Мацко,
С. С. Скляр,
А. Ю. Улитин,
Dmitry E. Matsko,
Е. Н. Имянитов,
А. Г. Иевлева,
Vazilo Ni,
Nikita Volkov,
А. А. Зрелов,
А. О. Бакшеева,
Д. В. Галкина
Publication year - 2021
Publication title -
sibirskij onkologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.115
H-Index - 4
eISSN - 2312-3168
pISSN - 1814-4861
DOI - 10.21294/1814-4861-2021-20-3-5-17
Subject(s) - temozolomide , medicine , oncology , chemotherapy , radiation therapy , dacarbazine , idh1 , progression free survival , idh2 , gene , biology , mutation , biochemistry